Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes
ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.14, sa.1, ss.26-33, 2014 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 14 Sayı: 1
- Basım Tarihi: 2014
- Doi Numarası: 10.5152/akd.2013.5009
- Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.26-33
- Anahtar Kelimeler: asymmetric dimethylarginine, diabetes type-2, glucose, oxidative stress, sex difference, regression analysis, CORONARY-ARTERY-DISEASE, ADVERSE CARDIOVASCULAR EVENTS, OXIDE SYNTHASE INHIBITOR, ENDOTHELIAL FUNCTION, METABOLIC SYNDROME, L-ARGININE, RHEUMATOID-ARTHRITIS, RENAL-DISEASE, RISK-FACTORS, TURKISH MEN
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
Objective: We investigated the association of serum asymmetric dimethylarginine (ADMA) with metabolic syndrome (MetS), type-2 diabetes and coronary heart disease (CHD) in the general population.